For many families living with peanut allergy, everyday life can feel like walking through a minefield. A crumb on a table, a ...

SAN ANTONIO -- Peanut oral immunotherapy (OIT) at maintenance doses 10 times lower than conventional dosing may be an effective strategy for desensitizing peanut-allergic patients, according to ...

Though a large proportion of patients receiving oral immunotherapy (OIT) for food allergy report gastrointestinal (GI) symptoms, a knowledge gap remains for the best approach to determine the ...

Please provide your email address to receive an email when new articles are posted on . Black patients with peanut allergies received oral immunotherapy less frequently than white patients. Patients ...

A recent study attempted to determine the prevalence of eosinophilic esophagitis (EoE) in a group of patients allergic to milk or egg and undergoing oral immunotherapy (OIT) to those foods, as well as ...

Thirty-six percent of patients treated with omalizumab were able to tolerate 2000mg of peanut protein and 2 other food allergens without experiencing an allergic reaction compared with 19% of ...

In February 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia, the first peanut powder product designed to help reduce the risk of severe peanut-induced allergic reactions through ...